Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.
about
Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapyPreliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South AfricaGender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: a systematic review.Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic reviewPredictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania.Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania.Predictors of Survival among Adult Ethiopian Patients in the National ART Program at Seven University Teaching Hospitals: A Prospective Cohort StudyLow haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort studyFurther benefits by early start of HIV treatment in low income countries: survival estimates of early versus deferred antiretroviral therapy.Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program.Treatment outcomes in a decentralized antiretroviral therapy program: a comparison of two levels of care in north central Nigeria.Four-year treatment outcomes of adult patients enrolled in Mozambique's rapidly expanding antiretroviral therapy program.Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, KenyaEarly mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysisMortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studiesImmunologic response to highly active antiretroviral therapy and mortality reduction in a cohort of human immunodeficiency virus-positive persons in Mozambique.Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review.Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in NigeriaIncreasing transfers-out from an antiretroviral treatment service in South Africa: patient characteristics and rates of virological non-suppression.Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana.Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in MumbaiNevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials.Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapyImplementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemiaDevelopment and validation of a clinical score for prognosis stratification in patients requiring antiretroviral therapy in sub-Saharan Africa: a prospective open cohort study.Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda.Retention in HIV Care and Predictors of Attrition from Care among HIV-Infected Adults Receiving Combination Anti-Retroviral Therapy in Addis Ababa.Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, IndiaAntiretroviral therapy in the Malawi police force: access to therapy and treatment outcomesGender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi.Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study.Community-based ART distribution system can effectively facilitate long-term program retention and low-rates of death and virologic failure in rural Uganda.Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.What happens to patients on antiretroviral therapy who transfer out to another facility?Current understanding of HIV-associated neurocognitive disorders pathogenesis.Malawi's contribution to "3 by 5": achievements and challengesTrue outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi.Impact of definitions of loss to follow-up on estimates of retention, disease progression, and mortality: application to an HIV program in Mozambique
P2860
Q28472810-B8A890E9-BFED-4765-85F0-26B544D1953EQ33279183-BD66C33C-9FE0-4550-9E6D-2EBCD1A4FD6CQ33282786-008CD932-D1A6-4A91-B39C-951BD9C570E8Q33302944-BB4CA3DE-6E0B-4C88-93E5-86D3295A7B49Q33330114-95D3AAC5-59EC-4512-8A37-04E842B157DCQ33479343-C140EA6A-03AC-44E1-8C8D-2B65E844BB33Q33596118-9D0AEF57-F98F-47C9-A206-8200FE50878FQ33638969-65C92FE6-5D75-467E-BF3A-0B01EE117D9EQ33718364-B2E981B7-8287-463B-BAED-681A71CC5836Q33782796-3A441BE7-73A4-42CD-A4A1-0050E2246645Q33852863-191B74A7-6772-43D7-B18A-500A88C97D93Q33869315-EC107B69-7959-4D7F-8E48-FC5F7FCA483EQ34087372-F1ADB5F4-463A-411F-8202-8856A13EA4C0Q34119037-262770E2-B529-4385-9041-892B3E4700EEQ34155253-D7F96ABC-8968-4563-90B2-D3FCD620A02AQ34240160-CCDDC4BC-6D93-4D76-9CA8-45196D11E90DQ34395892-9339AE4D-02EB-4BB4-BD39-6A0EE4F01F3AQ34592711-45B9793B-9447-4612-A68B-09A731AAF4F8Q34604679-B5ECE052-7371-4335-BB1A-2F5431BB0F59Q34614542-7350632C-F1B7-4DD1-823C-F8FB7A19C521Q34732899-16F11B80-68C8-4D5F-95A4-0533967F5C42Q34927469-46ABDF2E-4845-47DF-BDE7-3901BF59FDA6Q35008574-7B10C602-4782-4392-AB35-EDD021FEB92EQ35014739-BE112908-2637-484A-BF0C-963DEE0D172AQ35164547-0F9D524F-C603-4180-9F0C-A032E9DC88B4Q35170385-6756E3DB-7B6F-4F53-9A84-C45482401BCDQ35767307-E3FFAD88-898B-44F8-9FC7-DC3846E39E2BQ35780728-BBBCD8D2-3F7E-4828-89F8-73F31DA3BAF4Q35788262-922ABD7B-6145-4FB1-BB12-E938196424ABQ35917573-E6B05E81-D67A-4D12-A051-04C471C24CFAQ35938138-62F2A8A0-4CB6-4289-9EEE-123643B98D64Q35938490-7D6C4962-AAD0-45D7-8952-AAC709798392Q36112621-8F6BBB7A-6515-4BEF-90D9-4134C9F14D81Q36273986-2F62F331-0B32-478C-A2DC-6ED0E3FF5A78Q36325668-2C1B34F3-B2D6-4404-8E7B-31A44F10127CQ36571433-C4AC2908-B830-459C-BCDD-74BD577DD6ADQ36932005-F4EE938C-56EB-4A0B-87BC-5F32B6A372EFQ37084674-F4F23DF1-6CDB-4378-B27A-4A7064733C1BQ37084876-5B3D8A5C-FC56-47E1-8110-B86EE5B4851DQ37127890-7305DB08-F330-4979-A0BB-7843EE91DEB6
P2860
Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Initial response to highly act ...... treatment program in Botswana.
@en
type
label
Initial response to highly act ...... treatment program in Botswana.
@en
prefLabel
Initial response to highly act ...... treatment program in Botswana.
@en
P2093
P921
P1476
Initial response to highly act ...... treatment program in Botswana.
@en
P2093
Andrew Mujugira
Ava Avalos
C William Wester
Chris Vanderwarker
Hermann Bussmann
Howard Moffat
Ibou Thior
Lesego Busang
Ndwapi Ndwapi
Onalethata Johnson
P304
P356
10.1097/01.QAI.0000159668.80207.5B
P407
P50
P577
2005-11-01T00:00:00Z